Brandinium

Trademark search for:

ANGIOPEPTINE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2001-06-13 — Application filed
  • 2001-08-09 — Unresponsive/duplicate paper received
  • 2001-08-14 — Assigned to examiner
  • 2001-08-21 — Final disposition recorded
  • 2002-05-29 — Application abandoned
  • 2002-08-05 — Assigned to examiner
  • 2002-09-25 — Reinstated
  • 2002-09-25 — Approved for pub - principal register
  • 2002-11-13 — Notice of publication
  • 2002-12-03 — Published for opposition
  • 2003-02-25 — Noa mailed - sou required from applicant
  • 2003-02-25 — Notice of allowance cancelled
  • 2003-03-21 — Paper received
  • 2003-08-05 — Registered-principal register
  • 2005-05-20 — Teas change of correspondence received
  • 2008-04-17 — Case file in ticrs
  • 2009-04-01 — Automatic update of assignment of ownership
  • 2010-03-07 — Cancelled sec. 8 (6-yr)
  • 2010-03-07 — Final status recorded

Owner Information

IPSEN PHARMA S.A.S.
BOULOGNE-BILLANCOURT FR
Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
75780 Paris FR
Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
75780 Paris FR
Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
75780 Paris FR

Correspondent

CHARLES A MUSERLIAN HEDMAN & COSTIGAN
20TH FL
1185 AVE OF THE AMERICAS
NEW YORK, NY 10036

Filing Details

Filing Date:
2001-06-13
Status Date:
2010-03-07
Category:
Pharmaceuticals
Filing Year:
1994

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.